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Lack of Rybp in Mouse Embryonic Stem Cells
Impairs Cardiac Differentiation
Olga Ujhelly,1 Viktoria Szabo,2 Gergo Kovacs,2 Flora Vajda,2 Sylvia Mallok,3 Janos Prorok,4
Karoly Acsai,5 Zoltan Hegedus,6 Stefan Krebs,3 Andras Dinnyes,1,7 and Melinda Katalin Pirity2
Ring1 and Yy1 binding protein (Rybp) has been implicated in transcriptional regulation, apoptotic signaling and
as a member of the polycomb repressive complex 1, it has an important function in regulating pluripotency and
differentiation of embryonic stem cells (ESCs). Earlier, we had proved that Rybp plays an essential role in
mouse embryonic and central nervous system development. This work identifies Rybp, as a critical regulator of
heart development. Rybp is readily detectable in the developing mouse heart from day 8.5 of embryonic
development. Prominent Rybp expression persists during all embryonic stages, and Rybp marks differentiated
cell types of the heart. By utilizing rybp null ESCs in an in vitro cardiac differentiation assay, we found that
rybp null ESCs do not form rhythmically beating cardiomyocytes (CMCs). Gene expression profiles revealed a
downregulation of cardiac terminal and upregulation of germline-specific markers in the rybp null CMCs.
Furthermore, transcriptome analysis uncovered a number of novel candidate target genes regulated by Rybp.
Among these are several that are important in cardiac development and contractility such as Plagl1, Isl1, and
Tnnt2. Importantly, forced expression of rybp in rybp-deficient ESCs by a lentiviral vector was able to rescue
the mutant phenotype. Our data provide evidence for a previously unrecognized function of Rybp in heart
development and point out the importance of germ cell lineage gene silencing during somatic differentiation.
Introduction
Acomplex network of transcription factors governs thespatiotemporal patterns of gene expression in the organs
of the developing embryo proper. Transcription factors also
have important roles in postnatal and adult life in maintaining
the pattern of differentiated gene expression [1–3]. Ring1 and
Yy1 binding protein [Rybp, also known as Dedaf (Death
Effector Domain-Associated Factor), UniGene Mm.321633;
MGI:1929059] is a repressor protein that is also a member of
the mammalian polycomb repressive complex 1 (PRC1) [4].
First, Rybp was described as a binding partner for the poly-
comb group protein (PcG) Ring1A (Ring1; ortholog of
Drosophila dRing/Sce) and was also shown to associate with
Ring1B (Ring2/Rnf2; ortholog ofDrosophila dRing/Sce) and
M33 (Pc1; ortholog of Drosophila Pc), components of the
PRC1 multiprotein complex [5].
Our previous work showed that Rybp is selectively up-
regulated in distinct structures and cell types of the devel-
oping eye and the central nervous system (CNS), and it may
also play a role in the development of more mature neurons
[6,7]. We have also shown that rybp is essential for the
development of the mouse embryo proper and that homo-
zygous null mouse embryos cannot develop further im-
plantation [embryonic day 5.5 (E5.5)]. Notably, in a subset
of heterozygous animals and in rybp-/-4rybp+/ + chime-
ras, alterations in Rybp dosage induced striking neural tube
defects (NTDs) [6,7]. These findings have demonstrated the
integral role of Rybp at the early postimplantation and later-
stage CNS development. Simultaneously, early embryonic
lethality of the rybp homozygous null embryos were ob-
stacles to the study of the precise role of Rybp at later
developmental stages or the development of other organs.
In this study, the early lethal effect of Rybp deficiency
was overcome by utilizing rybp-/- embryonic stem cells
(ESCs) to model cardiac differentiation in the lack of Rybp.
Our results showed that ESCs lacking functional Rybp are
not able to form contractile cardiomyocytes (CMCs) and
that Rybp is important for the proper expression of several
key regulators of cardiac development. Recent data provide
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the first evidence that Rybp is required for the formation of
beating CMCs. This defines a novel role for Rybp in
mammalian heart formation and has implications for the
understanding of heart diseases.
Materials and Methods
Experimental procedures
All chemicals were purchased from Sigma-Aldrich and
all the culture reagents were from Invitrogen Life Tech-
nologies, unless otherwise specified.
Cell culture
Mouse R1 [8] [hereafter mentioned as rybp+/+ or wild-
type (WT) ESCs] and rybp null [6] (hereafter mentioned as
rybp-/- ) ESCs were thawed on mitomycin C (MitC; Sigma-
Aldrich) inactivated mouse embryonic fibroblast (MEF)
layer and cultured on gelatin-coated tissue culture plates as
described [9]. All cells were cultured at 37C in a humidi-
fied atmosphere containing 5% CO2. ESCs were cultured in
ESC medium, consisting of Dulbecco’s modified Eagle’s
medium GlutaMaxI, 15% (v/v) ES cell qualified fetal calf
serum (SLI Ltd.), 1% (v/v) nonessential amino acids, 1%
(v/v) Pen/Strep, 100mM 2-mercaptoethanol, and 1,000U/mL
1eukemia inhibitory factor (LIF, ESGRO; Chemicon/Milli-
pore). Medium was changed daily on mouse ESC cultures
and every 2 days during differentiation.
Expression vectors
To generate Rybp/Egfp expression constructs, we modi-
fied the original vector of Lois et al. to include a multiple
cloning site and an IRES sequence upstream of the Egfp
gene [10]. We cloned the Rybp cDNA to the multiple
cloning site by the Xba1/Nhe1 digest. We also substituted
the ubiquitin-C promoter by the promoter of the elongation
factor-1a (EF1a) gene.
Production of lentiviruses
All recombinant lentiviruses were produced by transient
transfection of 293T cells, as described byDull et al. [11]. The
packaging constructs were obtained through Addgene (ref
No: pMD2.G: 12259, pRSV-Rev: 12253, pMDLg/pRRE:
12251). The lentiviral particles were tested on 293T cells.
Transduction of ESCs
Lentiviral particles were added to ESCs in expansion
culture medium (MOI: 3–5) in the presence of 8 mg/mL
polybrene andwere centrifuged for 30min on 1,000g at 32C.
After overnight incubation at 37C, the full medium was
changed to fresh expansion medium. The cells were assayed
3 days after infection.
Immunoblot analysis of ESCs
Immunoblotting experiments of ESCs were carried out on
50 mg protein from whole cell lysates fractionated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis using
secondary antibodies conjugated with horseradish peroxi-
dase (HRP, AP132P; Millipore). The intensities of the re-
active bands were detected by Bio-Rad Opti-4CN Substrate
Kit (170-8235). Anti-Rybp (anti-Dedaf 1:1,000, AB3637;
Chemicon) was used for the detection of Rybp protein ex-
pression.
Immunocytochemistry
For immunofluorescence staining of the cells, cells were
plated onto 0.1% gelatin-coated coverslips and fixed with
4% paraformaldehyde (PFA) for 15min at room tempera-
ture. Cells were permeabilized with 0.05% Triton-X-100/
phosphate-buffered saline (PBS) for 10min at room tem-
perature, followed by blocking in 1% bovine serum albumin
for 1 h at room temperature. Cells were washed with PBS
and incubated overnight with primary antibody at 4C.
Primary antibodies used for this study include Oct3/4 anti-
body (C-10, 1:100; Santa Cruz), anti-Rybp (anti-Dedaf
1:1,000, AB3637; Chemicon), and cardiac Troponin T anti-
body [Ms mAb Cardiac Troponin T (1C11) 1:2,000, ab8295;
Abcam]. After washing thrice with PBS, cells were labeled
with Alexa Fluor647-conjugated secondary antibodies (for
Oct3/4 antibody and for anti-Rybp; Invitrogen) and Alexa
Fluor 488 Goat Anti-Mouse IgG (H +L) secondary antibody
(1:2,000, A11001; Invitrogen) for 1 h at room temperature.
Cells were then washed thrice with PBS and covered with
DAPI mountingmedium (VectaShield; Vector Laboratories).
Imaging was performed with an Olympus Cell Imaging
microscope (Olympus Corporation) and with an Olympus
LSM confocal microscope (Olympus Corporation). The
captured images of immunocytochemistry (ICC) were semi-
quantified using Olympus FluoView software.
Histology and immunohistochemistry
Embryos and adult mouse testis were collected, washed
thrice in PBS, fixed overnight with 4% PFA, embedded in
paraffin, and examined for general histological analysis.
Serial sections were generated, and 4-mm-thick sections
were hematoxylin and eosin stained for morphology as-
sessment and with anti-Rybp (anti-Dedaf 1:1,000, AB3637;
Chemicon) for monitoring endogenous Rybp staining. The
sections were analyzed and imaged by using a Zeiss Ax-
ioImager Z1 microscope (Carl Zeiss MicroImaging GmbH).
mRNA expression analysis
Total cellular RNA was isolated using the RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions.
The RNA prep was DNase treated (Promega), and tran-
scribed by the Superscript II cDNASynthesis Kit (Invitrogen,
by Life Technologies), as per the manufacturer’s instructions.
Quantitative real-time polymerase chain reaction (RT-PCR)
was performed in the SYBR Green JumpStart Taq ReadyMix
(S4438) for the QPCR green master mix, in the Rotor-Gene Q
real-time PCR machine (Qiagen). Gapdh was used as an in-
ternal control. Experiments were performed in triplicate and
repeated at least twice. See primer sequences in Supple-
mentary Table S1; SupplementaryData are available online at
www.liebertpub.com/scd.
In vitro cardiac differentiation
For cardiac differentiation, embryoid bodies (EBs) were
generated by the hanging-drop (HD) method as previously
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described [12]. For single-cell suspensions, the cells were
dissociated from monolayer culture with 0.25% trypsin-
EDTA [day 0 (d0)]. The cells were counted, and 800 cells/
20 mL differentiation medium (ESC medium without LIF)
were pipetted on the lid of a bacterial Petri-dish. The dish
was filled with PBS to prevent the droplets from drying
out. The cells were allowed to aggregate with the help of
gravity by reversing the Petri-dish lid. On day 2, individual
EBs were plated into a well of a 24-well plate containing
0.1% gelatin-coated coverslips. Differentiation medium was
changed every second day; the number of CMCs was con-
tinuously observed and recorded. The CMCs were further
processed as required (eg, monitoring [Ca2 + ] transient and
cell contraction or mRNA expression analysis) or fixed on
day 7 (d7), day 14 (d14), and day 21 (d21) for ICC.
Quantification of beating activity of EBs
Quantification of beating activity of EBs was performed
as previously described [13,14]. In brief, the number of
spontaneously beating clusters was recorded daily after
plating EBs under a Nikon TMS inverted light microscope
(Nikon Instruments, Inc.). The number of beating EBs was
represented as the percentage of the total plated EBs. The
cardiac beatings were further evaluated by grading of car-
diac beating (area of cardiac beating and beating rate) as
described earlier [13,14]. The results represent the mean –
SEM of three independent experiments. Statistical analyses
for a comparison of the percentage of the EB beating and
the grading of EB beating between groups were conducted
using a one-way ANOVA of SPSS Statistics version 18.0.
Monitoring [Ca2 + ]i transient and cell contraction
CMCs were loaded with 5mM Fluo-4 (Molecular Probes,
Inc.), in DMSO + 20% pluronic acid F-127 (Sigma-Aldrich)
in differentiation medium for 40min in the dark at room
temperature. Subsequently, myocytes were washed twice
with normal Tyrode’s solution and placed on the stage of an
inverted fluorescent microscope (Eclipse TE2000; Nikon).
The Tyrode’s solution contained the following (in mM): 144
NaCl, 0.4 NaH2PO4, 4 KCl, 0.53 MgSO4, 1.8 CaCl2, 5.5
glucose, and 5 HEPES, pH 7.4 with NaOH. Fluo-4 was ex-
cited at 480 nm; fluorescence emission was recorded at
535 nm by using appropriate filter sets (Chroma Technology).
Optical signals were recorded by a photon counting photo-
multiplier module (H7828; Hamamatsu) and sampled at
1 kHz. Cell contraction was determined by a video edge de-
tection system (VED-105; Crescent Electronics). Measure-
ments were performed, and data were analyzed using the
WinWCP software (V4.9.1. Whole Cell Electrophysiology
Analysis Program, John Dempster, University of Strath-
clyde). All experiments were performed at room temperature.
Global gene expression analysis
by next-generation sequencing
Cells from a 6 cm culture dish were harvested by re-
suspension in 500mL TRIzol (Invitrogen), and total RNA
was extracted with the TRIzol method following the man-
ufacturer’s protocol. RNA was quality controlled by the
nanodrop and bioanalyzer. High-quality RNA (RIN > 9 and
260/230 > 2; 260/280> 1.8) was converted to cDNA and
Illumina-compatible sequencing libraries using NuGEN
Ovation and Encore NGS kits. Barcoded libraries were
pooled and sequenced on an Illumina Genome Analyzer
GAIIx in the single read mode with 80 nt read length. Reads
were mapped to the mouse genome using TopHat [15].
Differentially expressed genes between wild-type and
rybp-/- ESCs were identified with DESeq and filtered for
having a fold change >1.5 or < - 1.5 and fdr <0.05. In the
case of increasing gene expression, the fold change value
was calculated by the expression ratio of the rybp-/ - and the
wild-type samples; however, when the gene expression
showed a decreasing tendency, the negative reciprocal of
this quotient was used for the fold change calculation.
Significant genes were uploaded to the Ingenuity Pathway
Analysis (IPA) (www.ingenuity.com) platform, where func-
tional enrichment studies were executed. The extent of over-
representation was quantified by the Benjamini–Hochberg
corrected significance value that was calculated by using the
Fisher’s Exact test. Gene annotation information was either
derived from the knowledge base of IPA or collected from the
Ensembl database using the BioMart tool.
Results
Rybp is abundantly expressed in the developing
mouse heart
To gain further support for the presence of Rybp in dif-
ferent organs besides CNS, we examined the distribution of
rybp mRNAs by Northern blotting analysis using total RNA
isolated from multiple mouse tissues. Our results demon-
strated that the major 4.7 kb isoform of rybp is highly ex-
pressed in the heart and also in other mouse tissues (kidney,
liver, skin, small intestine, thymus) (Fig. 1A). To confirm
that Rybp is also present at the protein level in the devel-
oping mouse heart, we examined its expression pattern by
utilizing anti-Rybp (anti-Dedaf) antibody on embryonic
sections. Rybp was shown to be readily detectable in the
developing heart from day 8.5 of embryonic development
(E8.5) (Fig. 1B). Prominent Rybp expression persisted
during all embryonic stages examined and Rybp marked
differentiated cell types of the heart, suggesting its in-
volvement in heart development and differentiation.
rybp null ESCs do not form rhythmically
beating CMCs
Abundant expression of Rybp in the heart prompted us to
investigate the role of Rybp in the regulation of cardiac
lineage commitment. To investigate the function of Rybp
during cardiac differentiation, we utilized rybp null (rybp-/- )
ESCs lacking functional Rybp protein product [6] (Fig. 1C).
Rybp-/ - ESCs are viable and display typical ES cell mor-
phology when grown on an MEF monolayer, forming round
and oval-shaped compact colonies, indistinguishable from
those that formed by the wild-type cells [6] (Fig. 1D). We
used the classic HD method to generate EBs as a common
intermediate during the in vitro differentiation of pluripotent
stem cells into CMCs (Fig. 2A and Materials and Methods).
Differentiation in brief, to induce ESC differentiation LIF,
was withdrawn from the culture medium and cells were kept
as HDs (800 cells/20 mL) to form EBs. Two days later, EBs
were transferred into a suspension culture system. At d4 of
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differentiation, the EBs were placed onto gelatin-coated
coverslips, one of each of the coverslips, and they were
grown for another 10 days. We subjected undifferentiated
(d0) and differentiated (d8 and d14) cell samples to analysis.
Both WT and rybp-/ - ESCs formed EBs and attached to the
gelatin-coated surface of the dishes, and WT ESCs formed
rhythmically beating CMCs in 6–14 days (Fig. 2B). We
found that although EBs could be derived from the rybp null
ESCs no beating colonies were observed from the mutant
cells (Fig. 2B). Out of 400 WT EBs, 93% formed beating
CMCs when they were allowed to attach on gelatin-coated
surfaces by the 14th day of differentiation while none was
beating from the rybp-/- genotype. Studies using Fluo-4
Ca2 + -sensitive dye confirmed that rybp-/ - CMCs cannot
produce intracellular [Ca2 + ] transient, indicating that the
defective Ca handling may contribute to the loss of cell
shortening (Fig. 2C). Analysis of gross morphology of de-
rived CMCs showed decreased colony size and less cell
content in the rybp null ESCs than the wild type at each
examined timepoints of in vitro cardiac differentiation (Fig.
2D). This suggested that in vitro cardiac differentiation was
affected by the absence of functional rybp.
Ascorbic acid fails to induce contractility
of the rybp-/ - CMCs
Ascorbic acid (ASC) is a known inducer of cardiac dif-
ferentiation and robustly enhances cardiac differentiation of
even cell lines without spontaneous cardiogenic potential.
Therefore, we have added ASC supplement in the differen-
tiation medium of the rybp null mutant cells to test whether
their cardiogenic potential can be further increased in the
FIG. 1. Rybp is abundantly expressed in the embryonic and adult mouse heart. (A) Northern blot analysis with rybp-
specific probe identifies a 4.7 kb major transcript in various mouse tissues and a 0.6 kb mRNA transcript expressed
abundantly only in testis. Several rybp isoforms at lower-molecular-weight range (0.6–0.8 kb) are also visible in multiple
tissues (kidney, liver, skin, small intestine thymus). The smallest molecular weight 0.6 kb isoform is not present in the heart
and the brain. A 2.5 kb transcript is only present in the small intestine. (B) Representative examples of immunohisto-
chemistry performed with an anti-Rybp (anti-Dedaf; Chemicon) antibody (dark gray staining, arrows) on counterstained
(light gray) sections from early postimplantation developmental stages (E8.5; E9.5) in normal mouse embryos showing
Rybp expression in the heart. (C) Immunostaining of wild-type (rybp+/+ ) and rybp-/ - ESCs for Rybp. ESCs were fixed and
immunostained with anti-Dedaf antibody (light gray) and DAPI (dark gray). Rybp null ESCs are not expressing Rybp.
Magnification: 20· . (D) Bright field images of undifferentiated wild-type and rybp-null ESC colonies. Rybp null ESCs are
viable and display a typical ES cell morphology. Colonies are composed of small cells attached to each other with a high N/C
(nucleoplasm/cytoplasm) ratio where a single cytoplasm is not detectable. Based on gross morphology, the rybp-/ - ESCs
show the typical mouse ES cell morphology. Cells were grown on the MEF layer. Scale bar = 100mm. ESCs, embryonic
stem cells; MEF, mouse embryonic fibroblast; Rybp, Ring1 and Yy1 binding protein.
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presence of ASC. We found that ASC was not able to induce
the contractility of the rybp-/- derivatives any further.
However, as a result of the ASC treatment, cell populations
from both genotypes grew and formed bigger colonies with
visibly more cell layers than without ASC (Fig. 2D). This
suggested that the rybp nullmutant cells cannot form beating
CMCs either spontaneously or after induction by ASC.
Lack of Rybp affects Isl1, Tnnt2, and Tbx3
expression in CMCs
To gain insights into underlying molecular events, we
have measured the expression of lineage-specific markers in
the rybp-/ - ESCs and compared them with the WT cells.
We have also measured marker gene expression during the
FIG. 2. The rybp+/+ and rybp-/ -
ESC lines show differences in
morphology of differentiated CMC
colonies and in contractile activity.
(A) Schematic representation of in
vitro cardiac differentiation. CMCs
were differentiated in vitro from
ESCs by using the hanging-drop
method. CMC colonies were grown
for 21 days and sampled at differ-
ent time points (eg, day 0, 7, 14 and
21) as further required. (B) Quan-
titative analysis of beating CMC
colonies derived from rybp+/+ and
rybp-/- ESCs. Vertical axis indi-
cates the percentage of beating
colonies; horizontal axis shows the
days of observation (day 8, 11, 17
and 21). Day 0 corresponds to the
undifferentiated ES cell stage (no
beating). Ninety-three percent of
rybp+/+ CMC colonies were beat-
ing from day 8, and rybp-/ - CMC
colonies showed weak contractile
activity only at day 17 (*5%) and
day 21 (*20%). (C) Original re-
cordings from 12 days old beating
rybp+/+ and nonbeating rybp-/ -
CMCs derived from mouse ESCs.
Left panel shows the changes of
intracellular Ca2 + concentration as
a Ca2 + -dependent fluorescent sig-
nal (F535 nm). Right panel shows
the corresponding cell shortening.
(D) Comparison of rybp+/ + and
rybp-/- CMC morphology with
and without ASC treatment at day 7
and 14 shows prominent differ-
ences. The CMCs derived from WT
(rybp+/+ ) ESC line had grown in
multiple layers, while the mutant
(rybp-/- ) colonies were scattered
and thin. CMCs derived from both
ESC lines formed larger and more
developed colonies with ASC in-
duction. ASC, ascorbic acid; CMC,
cardiomyocyte; WT, wild type.
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time course of cardiac differentiation (d2, 4, 8, 10, 14) in
both genotypes. Analysis revealed no significant changes in
gene expression level of the key pluripotency genes (Rex1,
Oct4, Nanog) (Fig. 3) and pan-mesodermal markers (T/Bra,
Gsc) (Fig. 3). The expression of all examined pluripotency
markers was progressively downregulated in both cell
populations by differentiation. This suggested that silencing
of pluripotency gene expression was properly executed in
the rybp-/- cells as well. Importantly, further gene expres-
sion analysis revealed downregulation of the terminal car-
diogenic marker cardiac troponinT (Tnnt2) in the mutants,
suggesting that cardiac lineage commitment was impaired in
FIG. 3. rybp-deficient ESCs are impaired in cardiac differentiation and expression of pluripotency (Rex1, Oct4, Nanog),
early mesodermal (Bra, Gsc), early cardiac (Isl1, Gata4, Gata6), T-box (Tbx3, Tbx5), and PcG (Jmj, Eed, Ezh2) genes
during in vitro cardiac differentiation. For quantitative real-time polymerase chain reaction (RT-PCR) analyses, RNA was
extracted, reverse transcribed from differentiated cardiac cells generated from WT and rybp-/- ESCs at day 0, 2, 4, 8, 10,
and 14 of differentiation, and analyzed for expression of marker genes. Gapdh transcripts were amplified as an internal
control. The expressions of the indicated markers were relative gene expression changes and were normalized to Gapdh
expression. Quantitative RT-PCR was performed with the primers listed in Supplementary Table S1. Values and
means: – SD *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; *****P < 0.00001 (n = 5) Statistical method: t-test type 3.
PcG, polycomb group protein.
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the rybp-/ - cells. By examining the earlier steps of cardiac
lineage commitment (Isl1, Gata4, Gata6 expression), we
found no significant differences in the expression of Gata4
and Gata6 expression (Fig. 3) while Isl1 expression was
impaired in the mutants (near 6 ·more in the WT cells) (Fig.
3). Isl1 is a homeobox transcription factor and an essential
regulator of cardiac progenitor differentiation. Rybp may
function as a member of PRC1 [4,16] and regulate the ex-
pression of homeobox-type transcription factors during heart
development. Therefore, we have also examined whether
the expressions of the T-box (homeobox-type) cardiac
transcription factors (Tbx3, Tbx5) were changed. CMCs
lacking rybp showed more than a 2-fold increase in Tbx3
expression compared with WT (Fig. 3); however, the level
of Tbx5 did not change significantly. Together, the data
suggested that while expression of pluripotency genes was
commonly downregulated, differentiation-driven activation
of some cardiac transcription factors, such as the homeobox-
type Isl1 and Tbx3, is different between cells expressing
Rybp and those lacking Rybp.
Polycomb-repressive complex 2 (PRC2) regulates the
balance between self-renewal and differentiation of ESCs.
Therefore, we have examined whether loss of rybp results in
the altered expression of PRC2 members. Our data showed
no significant alterations in PcG expression levels, including
Ezh2, Eed, and also PCR2 regulator Jmj. This suggests that
lack of rybp (Fig. 3) has no significant influence on the
expression level of the PRC2 members. These results also
showed that Rybp is necessary for the proper execution of
CMC differentiation.
Transcriptome analysis reveals a spectrum
of genes with altered expression profile in the rybp
null ESCs and CMCs
To examine possible gene expression alterations in a
broader spectrum and to examine which signaling pathways
are influenced by the lack of rybp, we have performed a
quantitative comparative transcriptome analysis with the
Illumina genome analyzer. We have compared the gene
expression profile of the undifferentiated rybp-/- and WT
ESCs (d0). We also performed analysis on differentiated
ESCs (d8, d14). D8 represents an earlier time point and d14
corresponds to a later time point of in vitro cardiac differ-
entiation and lineage commitment. Using the filtering cri-
teria of a two-or-greater fold change in expression and a
false discovery rate of less than 1%, 53 out of more than
20747 transcripts were differentially expressed at the un-
differentiated stage (d0) (Table 1). At the differentiated
stage 3%, 716 out of more than 23045 transcripts were at d8
(early stage) (Table 1) and 3.5%, 768 out of more than
21982 transcripts were at d14 (late stage) (Table 1). Under
these conditions, there were 25 transcripts with increased
expression in the rybp null ESCs (d0), while 30 transcripts
showed decreased expression (Supplementary Tables S2 and
S3). There were 393 transcripts with increased expression in
the rybp null ESCs at d8, while 325 transcripts showed
decreased expression (Supplementary Tables S2 and S3). At
d14 of cardiac differentiation, 478 transcripts showed in-
creased expression and 292 showed decreased expression
(Supplementary Tables S2 and S3). To identify the biolog-
ical processes in which genes transcriptionally affected in
rybp-/- ESCs are involved, we performed gene function
enrichment analysis using the IPA knowledge base. At the
undifferentiated stage (d0), ESCs displayed the most strik-
ing effect that was recorded in genes that were critical for
germ development. The transcriptome analysis revealed that
genes critical for germ development were de-repressed in
comparison to the WT ESCs (eg, Tex11, Tex13, Piwil2,
Dazl, Rnf17) (Supplementary Tables S2 and S3). These
genes are involved in the early stage of spermatogenesis and
are also expressed in primordial germ cells. Immunostaining
of adult testis confirmed that Rybp was localized in sper-
matogonia and weak staining of spermatocytes, but it was
not visible in spermatids or Sertoli or Leydig cells (Sup-
plementary Fig. S1). The transcriptome analysis of d8 and
d14 differentiated cells showed that other genes, involved in
the later stage of sperm development, are also de-repressed
(eg, Ddx4, Mael, Syce1, Sycp3). The IPA analysis revealed
a significant enrichment in different Gene Ontology Biolo-
gical Process categories, such as apoptosis (d8: Supple-
mentary Table S4; d14 Supplementary Table S5) in which
rybp is already known to be involved [17,18]. This obser-
vation suggests that rybp deficiency has an effect on the
transcriptome in ESCs, which is consistent with the data
obtained.
Altered expression level of genes important
for cardiovascular system development
and function in the rybp-deficient CMCs
To better understand the precise role of rybp in heart
development, we conducted functional enrichment assay
using IPA. The IPA analyses revealed that several cardio-
vascular-related gene sets can be found among most over-
represented physiological functions in the rybp-deficient
samples during cardiac differentiation (d8: Fig. 4A, day 14:
Fig. 4B). Genes of this functional category with significantly
different expression in WT and rybp-/ - ESCs are listed in
Supplementary Table S6 (d8) and Supplementary Table S7
(d14). Given these data, which provided additional evidence
that absence of rybp has an effect on the transcriptome in
ESCs and CMCs, we further analyzed the data obtained by
DNA-seq and searched for genes expressed in the heart and
for genes already known to have a cardiac phenotype in
mouse models. One of the most downregulated genes
expressed during cardiac differentiation is Plagl1 (d0: FC =
- 13.86, padj = 2.3 · 10 - 5; d8: FC = - 76.79, padj = 3.44·
10-77; d14: FC= -92.91, padj=2.68·10-79; Supplementary
Table S3). Plagl1 is an essential factor for cardiac mor-
phogenesis and is highly expressed in mouse hearts from
E8.5 to adulthood in a chamber-restricted pattern. In the
rybp null ESCs, Plagl1 is nearly absent at all timepoints of
Table 1. Gene Expression Changes in rybp-/ - Cells
Significant
increase
Significant
decrease
Genes
detected
d0 24 29 20747
d8 392 324 23045
d14 477 291 21982
d, day.
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cardiac differentiation. On the contrary, one of the most
upregulated gene during cardiac differentiation was Tbx3
(d0: FC= 4.63, padj = 5.95 · 10 - 3; d8: FC= 3.07, padj =
5.53 · 10- 7; d14: FC = 3.53, padj = 2.11 · 10 - 6 Supple-
mentary Table S2), which is required for pacemaker and
conduction system development in the mammalian heart.
Tbx3 was present nearly 5 · higher in the rybp mutants
ESCs compared with the WT (d0) and was induced nearly
4 · and 5 · more in CMCs during cardiac differentia-
tion. Six1, which functions in cardiac progenitor cells but is
FIG. 4. (A–B) Functional categories overrepresented among genes with significantly different expression in WT and
rybp-/- ESCs. Vertical axis indicates the negative log10 transformed significance value of the enrichment calculated by
Fisher’s Exact Test. The horizontal (intermitted) line shows the P= 0.05 threshold generally accepted as the criterion for the
selection of significant enrichments. (A): samples from day 8. (B): samples from day 14. (C) Immunocytochemical
localization of the cardiac Tnnt2 protein (light gray) in rybp+/+ and rybp-/- CMCs. Immunofluorescence analysis of CMCs
derived from wild-type (rybp+/+ ) and null mutant (rybp-/- ) ESCs at day 21 of differentiation using an anti-cardiac troponin
T antibody reveals downregulation of cardiac troponinT (Tnnt2) in the mutants. Scale bar: 100mm; Objective: 20 · . (D)
Semi-quantification of Tnnt2 levels of (C) by using Olympus FluoView software. Means are standard deviation – SD.
Values of P< 0.05 were accepted as significant (***P < 0.001). Statistical method: t-test type 3.
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stably silenced on cardiac differentiation, was also under-
represented in the rybp null ESCs (d0) and CMCs (d8; d14)
(d0: FC= 75.00, padj = 1.74 · 10 - 2; d8: FC = -5.23, padj =
5.73 · 10- 1; d14: FC = - 2.45, padj = 9.48 · 10 - 1) [19]. Our
DNA-Seq data indicate that key cardiac differentiation
pathways are impaired in the rybp null cells. This suggested
that altered Rybp dosage led to the improper execution of
the cardiac developmental program.
Rybp-deficient ESCs do not express structural
genes that are essential for contractility
of matured CMSc
The observation that rybp-/- CMCs cannot form rhyth-
mically beating CMCs motivated us to perform gene func-
tion enrichment analysis using the IPA knowledge base and
to examine the expression level of genes that are important
for CMC contractility. IPA analysis revealed that rybp-/-
CMCs have an almost complete lack of organized myofibrils
and Z-line genes (eg, Actn1, Myh6, Myh7, Myl2, Myl3,
Myl4, Myod, Myom1, Tnni1, Tnni2, Tnni3, Tnnt2) when
compared with normal WT CMCs (Supplementary Table
S8). Among these genes, Tnnt2 is a key component of the
troponin complex in CMCs. It has a regulatory role in
CMC contraction by anchoring troponinI and troponinC to
tropomyosin on the thin filaments in the sarcomeres and
also confers a Ca2 + dependence on sarcomere contraction.
Since the rybp-/ - CMCs exhibit deficiency in terminal
differentiation marker Tnnt2 mRNA induction, we analyzed
the spatial distribution of the Tnnt2 protein product as well
(Fig. 4C). Immunostaining of late-stage CMCs (d21) con-
firmed that cardiac Tnnt2 is localized in the cytoplasm and
exhibits strong staining in the wild-type CMCs and its
presence is less prominent in the rybp-/- cells (Fig. 4C, D).
These data demonstrate that the absence of Rybp interferes
with the normal expression of structural genes that are im-
portant for contractility, and it may have an important role
in regulating CMC contraction and heartbeat.
Rybp-deficient ESCs can be partially rescued
by ectopic rybp
Having shown that lack of rybp led to an impaired dif-
ferentiation and interferes with CMC contractility, we as-
sessed whether ectopic expression of Rybp might rescue the
cardiac phenotype (no rhythmically contracting CMCs,
impaired cardiac gene expression profile) of the rybp-/-
cells. We have postulated that by re-introducing rybp with a
lentiviral expression vector (rescued cells; rybpRes) we can
possibly induce contraction and restore the gene expression
profile in the rescued cells (Fig. 2C).
We re-introduced the rybp cDNA in the rybp-/ - ESCs by
the lentiviral expression system (Fig. 5A). To this purpose,
we generated stable ESC clones expressing the HA-tagged
rybp cDNA in rybp-/ - ESCs (rybpRes ESC lines) and tested
for Rybp expression by immunohistochemistry (Fig. 5D)
and western blotting (Fig. 5B). Lower Rybp expression was
detected in the rybpRes lines compared with WT ESCs by
western blot analysis. To see whether this lower protein
expression was due to the insufficiency of our lentiviral
expression system, we performed quantitative RT-PCR
analysis of rybp mRNA in the rybpRes lines. We found 10–
15 times higher expression of rybp mRNA in the rybpRes
lines compared with WT ESCs (Fig. 5C).
To determine whether this level of Rypb was functional,
both rybp-/ - and two independent rescued ESC lines
(rybpRes1; rybpRes2) were allowed to differentiate toward
CMCs. As the results showed, increased spontaneous beat-
ing activity in 20%–25% of the rescued CMCs (rybpRes1;
rybpRes2) was observed (Fig. 5E). Microscopic observations
revealed an increased cellularity in the rybpRes clones
compared with the parental rybp-/ - cells (Fig. 5F). Mole-
cular analysis of the gene expression profile confirmed that
ectopic Rybp was able to partially rescue the cardiac defect:
Isl1, Tnnti3, and Myh6 expression was partially restored
(Fig. 5G). Furthermore, germ line-specific Tex11, Ddx4,
and Piwil2 expression was downregulated in rybpRes lines,
suggesting that Rybp is a repressor of germ-specific genes
and absence of Rybp leads to activation of these promoters.
This experiment also showed that a normal dosage of Rybp
is required for both activation (some of the cardiac) and
repression (germ specific) of target genes.
Discussion
We have previously shown the correct dose of Rybp re-
quired for maintaining the appropriate spatiotemporal ex-
pression pattern and levels of Rybp for proper CNS
development, thereby providing an in vivo mouse model of
NTDs [6]. In this study, we provided evidence for the ex-
pression of Rybp during mouse heart development and an-
alyzed the consequences of the loss of rybp on in vitro
cardiac differentiation. We found that homozygous rybp-
deficient ESCs formed cell clusters but were not able to
differentiate into rhythmically beating CMCs in vitro, sug-
gesting the requirement of rybp for proper cardiac dif-
ferentiation and contractility. Gene expression analysis of
undifferentiated ESCs and CMCs during cardiac differentiation
FIG. 5. Reconstitution of Rybp expression and function in rybp-/- ESCs. (A) Lentiviral construct used for ectopic
expression of Rybp. (B)Western blot analysis of WT, rybp-/- , and two independent rescued ESC lines (rybpRes1; rybpRes2).
Western blot was probed with anti-Dedaf antibody (38 kDa). (C) Quantitative RT-PCR analysis of rybpRes clones compared
with WT cells. (D) Immunostaining of WT, rybp-/ - , and rybpRes ESC clones for Rybp expression. ESCs were fixed and
immunostained with anti-Dedaf antibody. (E) Spontaneous beating activity of differentiated WT, rybp-/ - , and rescued ESC
lines (rybpRes1; rybpRes2). Beating of differentiated EBs was counted at day 0, 8, and 11 of differentiation. (F) Microscopic
analysis of cellularity of differentiated WT, rybp-/- , and rescued ESC lines (rybpRes1; rybpRes2). (G) Quantitative RT-PCR
analysis of cardiac- and germ cell-specific differentiation markers. RNA was extracted, reverse transcribed from differ-
entiated cardiac cells generated from WT, rybp-/- , and rescued ESC lines (rybpRes1; rybpRes2) at day 0, 4, 8, and 14 of
differentiation, and analyzed for expression of differentiation markers Isl1, Tnni3, Myh6, Tex11, Ddx4, and Piwil2. Gapdh
transcripts were amplified as an internal control. Values and means: – SD *P< 0.05; **P < 0.01; ***P < 0.001;
****P< 0.0001; (n = 5) Statistical method: t-test type 3. EBs, embryoid bodies.
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demonstrated upregulation (Tbx3) and downregulation of
several transcription factors (Isl1, Plagl1) and structural
myofibril proteins (Actn1, Myh6, Myh7, Myl2, Myl3, Myl4,
Myocd, Myom1, Tnni1, Tnni2, Tnni3, Tnnt2) that are
critical for heart development.
Aiming at finding the causatives of the observed pheno-
type, we have analyzed whether an alteration in pluri-
potency, or key developmental and cardiac gene expression
is responsible for the impairment. One possible explanation
for the impaired cardiac differentiation of the mutants is that
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pluripotency gene silencing is incomplete during differen-
tiation, which may cause impaired differentiation. First, we
analyzed the key pluripotency gene (eg, Rex1, Oct4, Nanog)
expression levels and we concluded that there were no
significant changes in the kinetics of pluripotency gene
expression between the two cell populations (rybp-/ - vs.
rybp+/ + ). We concluded that proper silencing of pluri-
potency genes shows the expected kinetics, thus it cannot be
the causative of the observed differentiation defect.
Second, since the mammalian heart essentially has a
mesodermal origin, we have tested whether the mesoderm is
properly formed in the rybp mutant cells. We did not find a
difference in the expression pattern of the pan-mesodermal
marker Bra/T, which, as expected, was nearly absent in the
undifferentiated ESCs and transiently expressed during EB
formation peaking at d4. Gsc, which is another marker or
early mesodermal lineage commitment, exhibited normal
expression pattern in the rybp mutants as well. Notably, the
level of Gsc transcripts was 3-fold higher in the undiffer-
entiated rybp-/- than in the wild-type ESCs, suggesting that
an abundant pool of mesodermal precursors is available in
the rybp-/ - cells at the beginning of cardiac differentiation.
Taken together, these data showed that silencing of pluri-
potency gene expression and formation of mesoderm were
comparable in both the WT and the rybp null mutant cells
and that the defect in cardiac differentiation is probably due
to later-stage causatives. By examining the induction kinetic
of several key cardiac transcription factors, we have found
that induction of Isl1 expression was defective in the
rybp-/ - cells (10· vs. 2 · by d8; 12 · vs. 5 · by d10) (Fig.
3). Isl1 is an essential regulator of cardiac progenitor dif-
ferentiation and also an important transcriptional factor for
the development of the secondary heart field. Thus, one
possible explanation for the phenotype is that deficiency in
Isl1 expression leads to improper cardiac progenitor cell
differentiation and these resulted in defects in producing
functional CMCs in the rybp-/ - mutants. It is also
worthwhile to note that Isl1 belongs to the family of
homeodomain transcriptional regulators, thus it can be a
potential target of Rybp by a PcG-dependent fashion. PcG
proteins regulate homeotic gene expression and are es-
sential for organ development. It had been previously
shown that members of the PRC1 and PRC2 complexes
have essential roles in early embryonic development;
however, few of their target genes are known in mammals
[20,21]. Some of the PcG proteins were also shown to have
an essential function in mammalian heart development. A
key cardiac regulatory gene, six1, which also has altered
expression in the rybp-/ - CMCs, is suppressed by a PcG-
mediated mechanism by PRC2 member Ezh2 and Eed in
cardiac differentiation [22]. Loss of Ezh2 in cardiac pro-
genitors and in CMCs mediated by early myocardial
transcription factor Nkx2.5Cre resulted in lethal heart ab-
normalities and disrupted CMC gene expression. PRC1
member Rae28 knockout mice displayed cardiac anomalies
similar to congenital heart diseases in humans [23]. Rae28
sustains Nkx2.5 expression in CMCs and plays a key role
in cardiac lineage commitment [24]. Furthermore, in ES
cell-based assays, the loss of function of the Rybp binding
partner Yy1 resulted in a decrease in CMCs, whereas Yy1
gain of function enhanced the generation of cardiac cells
[25]. As far as the potential role of Rybp in PRC-mediated
repression is concerned, we still do not have a clear un-
derstanding of how Rybp functions as a PRC member or
how PcG complexes containing Rybp reach their targets.
Rybp is generally considered a PcG protein and a tran-
scriptional repressor [5,26], so downregulation of down-
stream targets that results from the absence of rybp seems
paradoxical. This leads to two alternate possibilities. Either
Rybp normally represses factors that would otherwise re-
press the target genes (absence of a putative repressor re-
sults in the downregulation of downstream targets), or
Rybp functions as a transcriptional activator on some
genes. In the first case, we would expect that the repressive
function of Rybp is typical of a PRC1 complex-dependent
regulation. In the second case, activation by Rybp would
most likely be independent of PcG proteins although it is
also possible that Rybp specifically displaces PRC1 from
chromatin and facilitates transcriptional activation in this
manner [27]. By the biochemical characterization of Rybp
Containing Multimeric Protein Complexes, much of which
should also contain Ring1 or Yy1 proteins, this paradox
might be easier to solve.
On the other hand, lack of Rybp did not result in a sig-
nificant change in the expression level of some other
homeodomain transcription factors. The level of Tbx5,
which is an essential gene of mammalian heart develop-
ment, did not change in our experiments, suggesting that
Rybp regulates cardiac transcription factors via different
regulatory circuits. It has also been reported that Rybp is
functioning as member of the noncanonical PRC1 complex
in a broad variety of target genes [4]. Rybp, as a member of
the noncanonical PRC, has an emerging and complex role in
the regulation of gene expression, differentiation, and de-
velopment. Furthermore, Rybp defines functionally different
PRC1 family complexes, thus preventing the incorporation
of other canonical PRC1 subunits, such as Cbx, Scm, and
Phc. The precise biological functions of these versatile
complexes are not known [4]. To clarify whether Rybp is
functioning as a member of the PRC1 complexes during
heart development certainly needs further investigations.
Notably, transcriptome analysis did not show any distur-
bance in PcG protein distribution between the undifferen-
tiated rybp-/- and WT ESCs or CMCs (Supplementary
Tables S2 and S3). This suggests that the lack of functional
Rybp had no significant effect on the expression of the
PRC1 and PRC2 members.
Downregulation of terminal cardiac marker Tnnt2 in the
rybp-/- CMCs may indicate the role of Rybp in regulating
structural proteins of the functional sarcomer. Lack of Tnnt2
in mouse models caused early embryonic lethality due to a
lack of heartbeats [28]. Our gene expression analysis
showed decreased expression of Tnnt2 in the rybp null
mutants (*2,000· vs. 500· by d8; 3,000 · vs. 500 · by d10
and 3,500 · vs. 500 · by d14); however, it was still abun-
dantly expressed even in the rybp-/ - mutant CMCs (500·)
compared with the WT CMCs (Fig. 3). This suggests that
perhaps not only the availability but also the functionality of
Tnnt2 is critical for the contraction of the WT CMCs.
Members of PRC2 are also required later in heart develop-
ment, as demonstrated by the conditional TNT-Cre in-
activated Eed knockout mice. However, Ezh2 inactivation
(another essential member of PRC2) by TNT-Cre did not
cause an overt phenotype, likely because of functional
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redundancy with Ezh1 [22]. Further experiments need to
clarify whether the assembly of functional sarcomeres is
impaired in the rybp mutants.
Our recent study also showed that the defect in contrac-
tility in the rybp null CMCs could not be restored by adding
ASC to the culture as a supplement. ASC has multiple ef-
fects on cell proliferation and differentiation, especially of
promoting mesenchymal cells toward adipogenesis, osteo-
genesis, chondrogenesis, and myogenesis. ASC is also able
to restore the contractile response in patients after heart
failure or myocardial infarction [29]. However, in our ex-
periments, ASC was not able to restore contractility of the
mutant CMCs but increased the cell mass of the rybp-/ - and
rybp+/+ CMCs. Little is known about the exact effect of
ASC, but it has been reported that reactive oxygen species
(ROS) regulate the intracellular signal transduction of the b-
adrenergic pathway, that is, its receptors, G-proteins and
adenylyl cyclase, function in the myocardium [30]. These
observations have led to the hypothesis that ROS directly
affect myocardial contractile function through alteration of
the b-adrenergic pathway. Future experiments need to
clarify whether members of the b-adrenergic pathway are
defective in the rybp-/- CMCs.
Importantly, re-introduction of rybp by a lentiviral ex-
pression vector in rybp deficient ESCs was able to rescue
the mutant phenotype and has partially restored contractility
of the rybp-/- CMCs. The appearance of contracting cells
was paralleled by the expression of early (Isl1) and late
(Tnni3) cardiac gene markers, thus suggesting their identity
as CMCs.
It is also important to mention that the absence of func-
tional Rybp had a significant effect on the cascade members
of germ cell development. This is in agreement with the
abundant expression of Rybp in the reproductive systems
and the recent observation of Hisada et al., that Rybp
functions as a de-repressor of germ specific genes in plu-
ripotent ESCs [31]. Our transcriptome analysis revealed that
abundant expression of germ line-specific genes persists
during the entire course of in vitro cardiac differentiation
and their downregulation is impaired. Our experiments
demonstrated that abundant germ line-specific gene ex-
pression persists during the entire time course of cardiac
differentiation in the mutants. Therefore, we cannot rule out
the possible effect of this abundant germ-specific gene ex-
pression on the inhibition of normal somatic differentiation
(eg, cardiac), which needs further investigation. Especially,
recent evidence indicates that germ line-specific genes [eg,
vasa (Ddx4), stella (Dppa3)] also function in other cell
types, distinct from the germ line or in facilitating differ-
entiation toward endodermal lineage commitment [32,33].
Both genes, Ddx4 and Dppa3, are aberrantly upregulated in
our rybp-deficient ESCs and Ddx4 is expressed throughout
cardiac-derived differentiation in rybp-/- CMCs. In our
experiments, forced expression of exogenous Rybp partially
restored the repressed state of genes that is important for
normal germ cell development in the rybp-deficient ESCs.
This underlines the function of Rybp in epigenetic regula-
tion at early-stage embryonic development [31] and pin-
points the importance of germ line gene silencing during
somatic differentiation.
In summary, we demonstrate, for the first time, that the
differentiation capacity of ESCs that lack rybp toward the
cardiogenic cell fate is severely impaired. We find that rybp
null ESCs are blocked in cardiac differentiation. Finally, we
present evidence that Rybp contributes to the contractility of
CMCs during stem cell differentiation.
Acknowledgments
The authors thank Dr. Joseph Locker for stimulating
discussions. They are indebted to Radone Gyugyi for the
superb technical assistance rendered.
This work was supported by NKTH-OTKA FP7 ‘‘Mobi-
lity’’ HUMAN-MB08C-80205; InduStem, PIAP-GA-2008-
230675; InduHeart, PEOPLE-IRG-2008-234390; InduVir,
PEOPLE-IRG-373 2009-245808; and Plurisys HEALTH-
2007-B-223485 and Research Center of Excellence 9878/
2015/FEKUT.
Author Disclosure Statement
No competing financial interests exist.
References
1. Davidson EH, JP Rast, P Oliveri, A Ransick, C Calestani,
et al. (2002). A genomic regulatory network for develop-
ment. Science 295:1669–1678.
2. Novershtern N, A Subramanian, LN Lawton, RH Mak, WN
Haining, et al. (2011). Densely interconnected transcrip-
tional circuits control cell states in human hematopoiesis.
Cell 144:296–309.
3. Odom DT, N Zizlsperger, DB Gordon, GW Bell, NJ Rinaldi,
et al. (2004). Control of pancreas and liver gene expression
by HNF transcription factors. Science 303:1378–1381.
4. Gao Z, J Zhang, R Bonasio, F Strino, A Sawai, et al.
(2012). PCGF homologs, CBX proteins, and RYBP define
functionally distinct PRC1 family complexes. Mol Cell
45:344–356.
5. Garcia E, C Marcos-Gutierrez, M del Mar Lorente, JC
Moreno and M Vidal. (1999). RYBP, a new repressor
protein that interacts with components of the mammalian
Polycomb complex, and with the transcription factor YY1.
EMBO J 18:3404–3418.
6. Pirity MK, J Locker and N Schreiber-Agus. (2005). Rybp/
DEDAF is required for early postimplantation and for
central nervous system development. Mol Cell Biol 25:
7193–7202.
7. Pirity MK, WL Wang, LV Wolf, ER Tamm, N Schreiber-
Agus, et al. (2007). Rybp, a polycomb complex-associated
protein, is required for mouse eye development. BMC Dev
Biol 7:39.
8. Nagy A, J Rossant, R Nagy, W Abramow-Newerly and JC
Roder. (1993). Derivation of completely cell culture-derived
mice from early-passage embryonic stem cells. Proc Natl
Acad Sci U S A 90:8424–8428.
9. Magin TM, J McWhir and DW Melton. (1992). A new
mouse embryonic stem cell line with good germ line con-
tribution and gene targeting frequency. Nucleic Acids Res
20:3795–3796.
10. Lois C, EJ Hong, S Pease, EJ Brown and D Baltimore.
(2002). Germline transmission and tissue-specific expres-
sion of transgenes delivered by lentiviral vectors. Science
295:868–872.
11. Dull T, R Zufferey, M Kelly, RJ Mandel, M Nguyen, et al.
(1998). A third-generation lentivirus vector with a condi-
tional packaging system. J Virol 72:8463–8471.
2204 UJHELLY ET AL.
12. Klincumhom N, MK Pirity, S Berzsenyi, O Ujhelly, S
Muenthaisong, et al. (2012). Generation of neuronal pro-
genitor cells and neurons from mouse sleeping beauty
transposon-generated induced pluripotent stem cells. Cell
Reprogram 14:390–397.
13. Rungarunlert S, N Klincumhom, I Bock, C Nemes, M
Techakumphu, et al. (2011). Enhanced cardiac differenti-
ation of mouse embryonic stem cells by use of the slow-
turning, lateral vessel (STLV) bioreactor. Biotechnol Lett
33:1565–1573.
14. Rungarunlert S, N Klincumhom, T Tharasanit, M Techa-
kumphu, MK Pirity, et al. (2013). Slow turning lateral
vessel bioreactor improves embryoid body formation and
cardiogenic differentiation of mouse embryonic stem cells.
Cell Reprogram 15:443–458.
15. Trapnell C, L Pachter and SL Salzberg. (2009). TopHat:
discovering splice junctions with RNA-Seq. Bioinformatics
25:1105–1111.
16. Morey L, G Pascual, L Cozzuto, G Roma, A Wutz, et al.
(2012). Nonoverlapping functions of the Polycomb group
Cbx family of proteins in embryonic stem cells. Cell Stem
Cell 10:47–62.
17. Zheng L, O Schickling, ME Peter and MJ Lenardo. (2001).
The death effector domain-associated factor plays distinct
regulatory roles in the nucleus and cytoplasm. J Biol Chem
276:31945–31952.
18. Stanton SE, JK Blanck, J Locker and N Schreiber-Agus.
(2007). Rybp interacts with Hippi and enhances Hippi-
mediated apoptosis. Apoptosis 12:2197–2206.
19. Delgado-Olguin P, Y Huang, X Li, D Christodoulou, CE
Seidman, et al. (2012). Epigenetic repression of cardiac
progenitor gene expression by Ezh2 is required for post-
natal cardiac homeostasis. Nat Genet 44:343–347.
20. Boyer LA, K Plath, J Zeitlinger, T Brambrink, LA Me-
deiros, et al. (2006). Polycomb complexes repress devel-
opmental regulators in murine embryonic stem cells.
Nature 441:349–353.
21. Simon JA and RE Kingston. (2009). Mechanisms of poly-
comb gene silencing: knowns and unknowns. Nat Rev Mol
Cell Biol 10:697–708.
22. He A, Q Ma, J Cao, A von Gise, P Zhou, et al. (2012).
Polycomb repressive complex 2 regulates normal devel-
opment of the mouse heart. Circ Res 110:406–415.
23. Takihara Y, D Tomotsune, M Shirai, Y Katoh-Fukui, K
Nishii, et al. (1997). Targeted disruption of the mouse ho-
mologue of the Drosophila polyhomeotic gene leads to
altered anteroposterior patterning and neural crest defects.
Development 124:3673–3682.
24. Shirai M, T Osugi, H Koga, Y Kaji, E Takimoto, et al.
(2002). The Polycomb-group gene Rae28 sustains Nkx2.5/
Csx expression and is essential for cardiac morphogenesis.
J Clin Invest 110:177–184.
25. Gregoire S, R Karra, D Passer, MA Deutsch, M Krane,
et al. (2013). Essential and unexpected role of Yin Yang 1
to promote mesodermal cardiac differentiation. Circ Res
112:900–910.
26. Tavares L, E Dimitrova, D Oxley, J Webster, R Poot, et al.
(2012). RYBP-PRC1 complexes mediate H2A ubiquityla-
tion at polycomb target sites independently of PRC2 and
H3K27me3. Cell 148:664–678.
27. Richly H, L Rocha-Viegas, JD Ribeiro, S Demajo, G
Gundem, et al. (2010). Transcriptional activation of polycomb-
repressed genes by ZRF1. Nature 468:1124–1128.
28. Nishii K, S Morimoto, R Minakami, Y Miyano, K Ha-
shizume, et al. (2008). Targeted disruption of the cardiac
troponin T gene causes sarcomere disassembly and defects
in heartbeat within the early mouse embryo. Dev Biol 322:
65–73.
29. Shinke T, J Shite, H Takaoka, K Hata, N Inoue, et al.
(2007). Vitamin C restores the contractile response to do-
butamine and improves myocardial efficiency in patients
with heart failure after anterior myocardial infarction. Am
Heart J 154:645.
30. Choi KM, YK Seo, HH Yoon, KY Song, SY Kwon, et al.
(2008). Effect of ascorbic acid on bone marrow-derived
mesenchymal stem cell proliferation and differentiation. J
Biosci Bioeng 105:586–594.
31. Hisada K, C Sanchez, TA Endo, M Endoh, M Roman-
Trufero, et al. (2012). RYBP represses endogenous retro-
viruses and preimplantation- and germ line-specific genes
in mouse embryonic stem cells. Mol Cell Biol 32:1139–
1149.
32. Gustafson EA and GM Wessel. (2010). Vasa genes:
emerging roles in the germ line and in multipotent cells.
Bioessays 32:626–637.
33. Wongtrakoongate P, M Jones, PJ Gokhale and PW An-
drews. (2013). STELLA facilitates differentiation of germ
cell and endodermal lineages of human embryonic stem
cells. PLoS One 8:e56893.
Address correspondence to:
Dr. Melinda Katalin Pirity
Institute of Genetics
Biological Research Centre
Hungarian Academy of Sciences
Szeged H-6726
Hungary
E-mail: pirity.melinda@brc.mta.hu
Received for publication December 8, 2014
Accepted after revision May 22, 2015
Prepublished on Liebert Instant Online June 3, 2015
RYBP IS IMPORTANT FOR CARDIOMYOCYTE CONTRACTILITY 2205
